Pharos Capital Group related stories
All articles and analysis
Pharos Fund III wrapping up long fundraise at $500 mln, above targetPharos Capital Group, the Dallas-based private equity firm founded by Fortune 500 company director Kneeland Youngblood and two Goldman Sachs veterans, is nearing a final close of its third growth equity/buyout fund, with an expected total of $500 million after more than two years in the market, according to a person familiar with the firm.
- Pharos Capital Group names new senior financial analyst
Dallas and Nashville-based private equity firm Pharos Capital Group said Tuesday that it has hired Joshua Brown as a senior financial analyst. Brown, who is based in the firm's Dallas office, will be responsible for deal review, financial due diligence and financial modeling. Previously, he worked at the Chicago-based William Blair & Company where he served as an investment banking analyst in the healthcare group.
- Pharos Capital Group announces new hire
Pharos Capital Group said Tuesday that it has appointed Brett Jackson as a senior financial analyst in the firm’s Nashville office. Previously, he worked at the Little Rock, Arkansas-based Stephens Inc., where he served as an investment banking analyst. Pharos is a private equity firm based in Dallas and Nashville.
- Pharos Capital Group promotes Pace to associate
Pharos Capital Group said Thursday that it has promoted Doug Pace to senior financial analyst. Prior to joining Pharos Capital Group, Pace, who is based in the firm’s Nashville office, worked at Edgeview Partners where he served as an analyst. Based in Dallas and Nashville, Pharos Capital Group is a private equity firm.
- Emerging manager trade chief steps down
Ed Dandridge, the outspoken head of the National Association of Investment Companies, worked to highlight the strong performance of diverse and minority-led firms.
- Pharos collects $405m for Fund III
Pharos' third vehicle, a 2010 vintage, has surpassed its $400 million target.
- Pharos Capital Sells Stake in Pioneer Surgical: CORRECTED
Pharos Capital Group has sold its stake in Pioneer Surgical Technology for $130 million. Earlier this week, RTI Biologics, which is backed by Water Street Healthcare Partners, said it was buying Pioneer /2013/06/18/beringea-sell-pioneer-surgical-technology-rti-biologics-130-mln/ from Beringea. RTI paid $130 million for Pioneer. Marquette, Mich.-based Pioneer makes and distributes metal and synthetic implant products for the orthopedics, biologics, spine, trauma and cardiothoracic markets.
- In this issue …
In this issue ? 2008-06-01 Staff Writer COMPANIES Alchemy Partners 6 Abraaj Capital 36 Actis 36,64 Advent International 8, 26 AIG 38 Alpha Associates 78&l
- TPG, Pharos acquire asset manager for $480m
The two Texas buyout firms have teamed up to buy American Beacon Advisors, a non-core asset American Airlines’ parent company first shopped in 2003.
- NY State to allocate $1bn for ‘emerging’ managers(4)
The New York State Common Retirement Fund is upping its allocation to so-called emerging managers, including women- and minority-owned firms.